Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Eric Oulashin |
|---|---|
| Location: | Beaverton, Oregon, USA |
| Users: | 133 |
| Nodes: | 16 (0 / 16) |
| Uptime: | 493088:00:21 |
| Calls: | 8,074 |
| Calls today: | 2 |
| Files: | 9,432 |
| D/L today: |
2,586 files (1,508M bytes) |
| Messages: | 404,518 |